{"DataElement":{"publicId":"7124979","version":"1","preferredName":"Tumor Segment Percent Total Cellularity Integer","preferredDefinition":"An integer number between 0 and 100 to capture the percent of total cellularity in the tumor segment.","longName":"7120634v1.0:6847952v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7120634","version":"1","preferredName":"Tumor Segment Percent Total Cellularity","preferredDefinition":"Sufficient total material from each patient, divided to yield a minimum of one aliquot, preferably divided into three to five aliquots, of specified cancer tissue suitable for processing for proteomic and genomic analysis._A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred)._Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition._The determination of the amount of degree, quality or condition of cells present in a sample.","longName":"7119487v1.0:7120632v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"7119487","version":"1","preferredName":"Tumor Segment","preferredDefinition":"Sufficient total material from each patient, divided to yield a minimum of one aliquot, preferably divided into three to five aliquots, of specified cancer tissue suitable for processing for proteomic and genomic analysis.","longName":"C162622","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Segment","conceptCode":"C162622","definition":"Sufficient total material from each patient, divided to yield a minimum of one aliquot, preferably divided into three to five aliquots, of specified cancer tissue suitable for processing for proteomic and genomic analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9B7C823A-3A71-01FE-E053-F662850AC3D6","latestVersionIndicator":"Yes","beginDate":"2020-01-06","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-06","modifiedBy":"ONEDATA","dateModified":"2020-01-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7120632","version":"1","preferredName":"Percent Unit Total Cellularity Measurement","preferredDefinition":"A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).:Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.:The determination of the amount of degree, quality or condition of cells present in a sample.","longName":"C48570:C25304:C111153","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percent Unit","conceptCode":"C48570","definition":"A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Total","conceptCode":"C25304","definition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cellularity Measurement","conceptCode":"C111153","definition":"The determination of the amount of degree, quality or condition of cells present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9B7C7377-E120-0202-E053-F662850A097C","latestVersionIndicator":"Yes","beginDate":"2020-01-06","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-06","modifiedBy":"ONEDATA","dateModified":"2020-01-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435029","version":"1","preferredName":"Molecular Abnormality","preferredDefinition":"Abnormalities that occur in human cells and tissues and models of human cancer.","longName":"C3910","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07432BB3-787B-25DB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9B7C7377-E131-0202-E053-F662850A097C","latestVersionIndicator":"Yes","beginDate":"2020-01-06","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-06","modifiedBy":"KNABLEJ","dateModified":"2020-02-13","changeDescription":"1/22/20 jk released per CPTAC SME's review of PRAD Path Review CDE set. 1/6/20 jk created for CPTAC Path Review CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6847952","version":"1","preferredName":"Integer","preferredDefinition":"A positive number with no fractional part between 0 and 100.","longName":"6847952v1.0","context":"OCCPR","contextVersion":"1","type":"Non-enumerated","dataType":"Integer","minLength":"1","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008541","version":"1","preferredName":"Numbers","preferredDefinition":"the set of non-negative integers.","longName":"NUMS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227CE66-2830-4A7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433737","version":"1","preferredName":"Integer","preferredDefinition":"A number with no fractional part.","longName":"C45255","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4769-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-25","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-25","modifiedBy":"ONEDATA","dateModified":"2005-11-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8F867DFE-8763-5C6C-E053-F662850A9F8B","latestVersionIndicator":"Yes","beginDate":"2019-08-07","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-08-07","modifiedBy":"KNABLEJ","dateModified":"2020-01-22","changeDescription":"1/22/20 jk released per CPTAC SME's review of PRAD Path Review CDE set.  8/7/19 jk created for CPTAC baseline CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6601275","version":"1","longName":"Brain","context":"OCCPR"},{"publicId":"6779545","version":"1","longName":"LGG Local Pathology","context":"OCCPR"},{"publicId":"6779546","version":"1","longName":"LGG Pathology Review","context":"OCCPR"},{"publicId":"6779607","version":"1","longName":"BLCA Local Pathology","context":"OCCPR"},{"publicId":"5635361","version":"1","longName":"Bladder","context":"OCCPR"},{"publicId":"6779608","version":"1","longName":"BLCA Pathology Review","context":"OCCPR"},{"publicId":"6570064","version":"1","longName":"Stomach","context":"OCCPR"},{"publicId":"6779567","version":"1","longName":"STAD Local Pathology","context":"OCCPR"},{"publicId":"6779568","version":"1","longName":"STAD Pathology Review","context":"OCCPR"},{"publicId":"10000439","version":"1","longName":"Thyroid","context":"OCCPR"},{"publicId":"6779572","version":"1","longName":"THCA Local Pathology","context":"OCCPR"},{"publicId":"6779573","version":"1","longName":"THCA Pathology Review","context":"OCCPR"},{"publicId":"6776735","version":"1","longName":"Eye","context":"OCCPR"},{"publicId":"6779575","version":"1","longName":"UVM Local Pathology","context":"OCCPR"},{"publicId":"6779576","version":"1","longName":"UVM Pathology Review","context":"OCCPR"},{"publicId":"6570063","version":"1","longName":"Cervix","context":"OCCPR"},{"publicId":"6779610","version":"1","longName":"CESC Local Pathology","context":"OCCPR"},{"publicId":"6779611","version":"1","longName":"CESC Pathology Review","context":"OCCPR"},{"publicId":"6776762","version":"1","longName":"Bile duct and Liver","context":"OCCPR"},{"publicId":"6779539","version":"1","longName":"CHOL Local Pathology","context":"OCCPR"},{"publicId":"6779540","version":"1","longName":"CHOL Pathology Review","context":"OCCPR"},{"publicId":"6779542","version":"1","longName":"LIHC Local Pathology","context":"OCCPR"},{"publicId":"6779543","version":"1","longName":"LIHC Pathology Review","context":"OCCPR"},{"publicId":"6601282","version":"1","longName":"Esophagus","context":"OCCPR"},{"publicId":"6779554","version":"1","longName":"ESCA Local Pathology","context":"OCCPR"},{"publicId":"6779555","version":"1","longName":"ESCA Pathology Review","context":"OCCPR"},{"publicId":"5635376","version":"1","longName":"Prostate","context":"OCCPR"},{"publicId":"6779562","version":"1","longName":"PRAD Local Pathology","context":"OCCPR"},{"publicId":"6779563","version":"1","longName":"PRAD Pathology Review","context":"OCCPR"},{"publicId":"7218867","version":"1","longName":"Head and Neck","context":"OCCPR"},{"publicId":"7634287","version":"1","longName":"HNSCC Pathology Review","context":"OCCPR"},{"publicId":"10000348","version":"1","longName":"Melanoma","context":"OCCPR"},{"publicId":"7639000","version":"1","longName":"CM Pathology Review","context":"OCCPR"},{"publicId":"7638999","version":"1","longName":"HNSCC Local Pathology","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Percent total cellularity","type":"Preferred Question Text","description":"Percent total cellularity","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9BA237E7-EEF5-590C-E053-F662850AEBDF","latestVersionIndicator":"Yes","beginDate":"2020-01-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-08","modifiedBy":"COLBERTM","dateModified":"2022-09-11","changeDescription":"8/17/21 jk added CM Path Rpt CSI. 7/12/21 jk added HNSCC Path Rpt CSI. 4/30/20 jk added CPTAC LGG Path CSI. 1/22/20 jk released per CPTAC SME's review of PRAD Path Review CDE set. 1/8/20 jk created for CPTAC Path Review and Local Path CRFs; applicable to all tumor types.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}